1. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment 
Mei Lu, Yueren Zhou, Irina V. Haller, Robert J. Romanelli, Jeffrey J. VanWormer, Carla V. Rodriguez, Heather Anderson, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Amandeep Sahota, Jennifer Vincent, Christopher L. Bowlus, Keith Lindor, Talan Zhang, Sheri Trudeau, Jia Li, Loralee B. Rupp, Stuart C. Gordon 
Clinical Gastroenterology and Hepatology 
Volume 16, Issue 8, Pages e1 (August 2018)
DOI: /j.cgh
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
Overall trends of prevalence and incidence of PBC (2006–2014).
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

3. Figure 2
PBC (A) prevalence and (B) incidence by age, gender, and race.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

4. Figure 3
Multivariable Cox regression: aHRs for all-cause mortality. UDCA treatment status is propensity score–adjusted (see Table 3). Bilirubin units are provided in IU/mL. Normal was defined by the manufacturer of the assay used at each site. Age category is defined at index date. LCL, lower confidence limit; UCL, upper confidence limit; ULN, upper limit of normal. ∗, 1-2 times the upper limit of normal.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions